The Quality of End‐of‐Life Care in Japan in 2021: A Mortality Follow‐Back Study During the COVID ‐19 Pandemic
Die Qualität der Versorgung am Lebensende in Japan 2021: eine Mortality-Follow-Back-Studie während der COVID-19-Pandemie
Geriatrics & Gerontology International · 2026-01 · 26 (1)
DOI: 10.1111/ggi.70347 ↗Auf einen Blick
Die Studie untersuchte die Qualität der Versorgung am Lebensende und das Erreichen eines guten Sterbens in Japan während der Pandemie. Die Qualität war insgesamt hoch, „family care“ wurde jedoch am niedrigsten bewertet.
Fragestellung
Wie wurde die Qualität der Versorgung am Lebensende und das Erreichen eines guten Sterbens in Japan 2021 während der COVID-19-Pandemie beurteilt, besonders bei Hospitalisierungen?
Methode
Fragebogen an 26 969 Angehörige Verstorbener ab 20 Jahren; Auswertung von 3619 Hospitalsterbefällen. Bewertung mit Care Evaluation Scale und Good Death Inventory.
Ergebnisse
10 890 Antworten (50,9 %); 3619 Hospitalsterbefälle analysiert. Die wahrgenommene Qualität lag bei 73,3 %–92,9 %. „Family care“ war am niedrigsten; beim Item „being free from physical distress“ lagen die Werte bei 37,6 % bei Krebs und 65,8 % bei Senilität.
Schlussfolgerung der Autor:innen
Während der Pandemie wurde „family care“ niedriger bewertet, war unter Besuchsbeschränkungen aber besonders wichtig. Die personenzentrierten Good-death-Items unterschieden sich nicht nach Krankheit.
Kernaussagen
- Wahrgenommene EOL-Qualität insgesamt hoch: 73,3 %–92,9 %
- „Family care“ am niedrigsten bewertet
- „Being free from physical distress“: 37,6 % bei Krebs, 65,8 % bei Senilität
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 19.01.2026. Verfasst von Richi Takahashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Policy Evaluation, Institute for Cancer Control, National Cancer Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Terminal Care, COVID-19, Quality of Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare, Japan, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Background
The COVID‐19 pandemic disrupted end‐of‐life (EOL) care for patients with incurable non‐communicable diseases. This study evaluated the overall quality of EOL care and achievement of a good death in Japan during the pandemic, particularly focusing on hospital deaths.
Methods
Questionnaires were mailed to 26 969 bereaved family members of patients aged ≥ 20 years who died in 2021 from the 10 leading causes of death in Japan. Causes were grouped into six categories: cancer, cardiovascular disease, renal failure, respiratory diseases, neurocognitive disorders, and senility. Outcomes were (1) perceived quality of EOL care, measured with the Care Evaluation Scale (CES), and (2) achievement of a good death, measured with the Good Death Inventory (GDI).
Results
We received 10 890 responses (50.9%); 3619 hospital deaths were analyzed. Perceived quality of EOL care was generally high during the pandemic (73.3%–92.9%). Within CES, “family care” was lowest across diseases, yet 73.3%–78.6% perceived care as good quality. For the GDI item “being free from physical distress,” achievement was 37.6% in cancer and 65.8% in senility. After adjusting for age and sex, achievement of a good death did not vary by disease, except for pathophysiology‐related symptom items (e.g., pain and cognitive function).
Conclusion
During the pandemic, “family care” was rated lower, yet it became especially important under visiting restrictions. Approximately one in three people dying of senility experienced pain, indicating a need for closer attention from caregivers. Within good‐death outcomes, person‐centered items did not vary by disease—an encouraging finding in universal EOL care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Policy Evaluation, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
- Division of Quality Assurance Programs, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
- Department of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Palliative and Supportive Care, Palliative Care Team, and Seirei Hospice, Seirei Mikatahara General Hospital, Shizuoka, Japan.
- Research Association for Community Health, Hamamatsu, Japan.
- Initiative for Clinical Epidemiological Research, Tokyo, Japan.
ORCID-Profile: Richi Takahashi, Hiroshi Yamamoto
Förderung
- Japan Society for the Promotion of Science
- Ministry of Health, Labour and Welfare, Japan
- Ministry of Health, Labour and Welfare
Zitieren
APA
Takahashi, R., Nakazawa, Y., Miyashita, M., Morita, T., Okumura, Y., Kizawa, Y., Kawagoe, S., Yamamoto, H., & Ogawa, A. (2026). The Quality of End‐of‐Life Care in Japan in 2021: A Mortality Follow‐Back Study During the COVID ‐19 Pandemic. Geriatrics & Gerontology International, 26(1). https://doi.org/10.1111/ggi.70347
Vancouver
Takahashi R, Nakazawa Y, Miyashita M, Morita T, Okumura Y, Kizawa Y, et al. The Quality of End‐of‐Life Care in Japan in 2021: A Mortality Follow‐Back Study During the COVID ‐19 Pandemic. Geriatrics & Gerontology International. 2026;26(1). doi:10.1111/ggi.70347
BibTeX
@article{Takahashi2026,
author = {Takahashi, Richi and Nakazawa, Yoko and Miyashita, Mitsunori and Morita, Tatsuya and Okumura, Yasuyuki and Kizawa, Yoshiyuki and Kawagoe, Shohei and Yamamoto, Hiroshi and Ogawa, Asao},
title = {The Quality of End‐of‐Life Care in Japan in 2021: A Mortality Follow‐Back Study During the COVID ‐19 Pandemic},
journal = {Geriatrics & Gerontology International},
year = {2026},
volume = {26},
number = {1},
doi = {10.1111/ggi.70347}
}
EUVIMED